DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Norway
  • /
  • Healthcare
Author Program NEWCreate Narrative
OMDA logo

Omda AS Stock Price

OB:OMDA Community·NOK 881.8m Market Cap
  • 1 Narratives written by author
  • 1 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

OMDA Share Price Performance

NOK 0
-48.00 (-100.00%)
​
NOK 50.00
Fair Value
NOK 0
-48.00 (-100.00%)
​
Price NOK 0
Tue, 2 Jun 26
Fair ValueNOK 50.00
Share Pricen/a

OMDA Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value NOK 50 16.2% undervalued intrinsic discount

Healthcare Digitization Will Spark Competitive Gains Amid Regulatory Pressures

0users have liked this narrative
1users have commented on this narrative
1users have followed this narrative
OMDA logo
Omda
16.2% undervalued intrinsic discount

Healthcare Digitization Will Spark Competitive Gains Amid Regulatory Pressures

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 2 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
OMDA logo

OMDA: Q4 Execution And 2026 Guidance Conservatism Will Shape Future Upside Potential

Fair Value: NOK 50 16.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with high growth potential.

2 Risks
3 Rewards
View Full Analysis

Omda AS Key Details

NOK 499.1m

Revenue

NOK 256.2m

Cost of Revenue

NOK 242.9m

Gross Profit

NOK 274.0m

Other Expenses

-NOK 31.1m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 18, 2026
-1.52
48.67%
-6.23%
-2,438.6%
View Full Analysis

About OMDA

Founded
1999
Employees
249
CEO
Sverre Flatby
WebsiteView website
omda.com

Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a clinical imaging mobile application; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow solution; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, a patient data transfer tool; Omda Plutus, an audit and workflow monitoring platform; Omda S7, an e-care communications platform; and Omda XDS, a patient data storage and management solution. In addition, the company offers Omda Fertsoft, a data solution for advanced-assisted reproductive technology clinics; Omda iPana Hospital, a digital maternity solution; Omda iPana Maternity, a cloud-based platform for women's maternity care; and Omda Partus, a data solution for the maternity sector, as well as health analytics products comprising Omda Compos, a medical data management solution; and Omda MedSciNet for collection, analysis, and management of medical data. Further, it provides Omda Optima that enables emergency organizations to test resource distribution and operational strategy through digital simulations; Omda CoordCom, an integrated response management and complete reliability platform; Omda AMIS, a digital platform for processing emergency calls and coordinating various aspects of the medical response; and Omda Paratus, an emergency response system. The company was formerly known as CSAM Health Group AS and changed its name to Omda AS in September 2023. Omda AS was founded in 1999 and is headquartered in Oslo, Norway.

Recent OMDA News & Updates

User avatar
Narrative Update • Jun 02

OMDA: Q4 Execution And 2026 Guidance Conservatism Will Shape Future Upside Potential

Narrative Update on Omda The updated analyst price target for Omda shifts from a fair value of NOK57.00 to NOK50.00 as analysts factor in a higher discount rate, more cautious revenue growth assumptions, improved profit margin expectations, and a lower future P/E multiple. Analyst Commentary Recent Street research on Omda highlights a mix of optimism about growth and execution, paired with more cautious valuation assumptions and price target resets.

Recent updates

No updates

Omda AS Competitors

MEDI logo

Medistim

Symbol: OB:MEDI
Market cap: NOK 4.5b
NORDH logo

Nordhealth

Symbol: OB:NORDH
Market cap: NOK 2.0b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide